BTK is involved in regulation of proliferation, differentiation and survival of B cells and in functions of innate immune cells, as shown by the altered innate immune responses observed in monocytes, dendritic cells (DC) and neutrophils of XLA patients [6–9]. The gene discussed is BTK; the disease is Bruton-type agammaglobulinemia.